Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo

Neuropharmacology

Volumn 52, Issue 5, 2007, Pages 1219-1228

  Corona, Juan Carlos ^a   Tapia, Ricardo ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

AMPA receptor; Amyotrophic lateral sclerosis; Calcium ions; Excitotoxicity; Motoneurons

Indexed keywords

1 NAPHTHYLACETYLSPERMINE; 1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,NO,NO TETRAACETIC ACID TETRAKIS(ACETOXYMETHYL ESTER); AMPA RECEPTOR; CALCIUM CHELATING AGENT; CALCIUM ION; PYRUVIC ACID; SPERMINE DERIVATIVE; UNCLASSIFIED DRUG; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; CHOLINE ACETYLTRANSFERASE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL LOSS; CONTROLLED STUDY; IN VIVO STUDY; LUMBAR SPINAL CORD; MALE; MICRODIALYSIS; NERVE CELL NECROSIS; NONHUMAN; PARALYSIS; PERFUSION; PRIORITY JOURNAL; RAT; SPINAL CORD MOTONEURON; ANIMAL; CALCIUM SIGNALING; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; ENERGY METABOLISM; EXTRACELLULAR SPACE; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTONEURON; NERVE DEGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD; WISTAR RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMINO ACIDS; ANIMALS; CALCIUM; CALCIUM SIGNALING; CHOLINE O-ACETYLTRANSFERASE; ENERGY METABOLISM; EXCITATORY AMINO ACID AGONISTS; EXTRACELLULAR SPACE; IMMUNOHISTOCHEMISTRY; MALE; MOTOR NEURONS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PARALYSIS; PYRUVIC ACID; RATS; RATS, WISTAR; RECEPTORS, AMPA; SPINAL CORD;

EID: 34047131622     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.12.008     Document Type: Article

References (57)

1. Alexianu M.E., Ho B.K., Mohamed A.H., La Bella V., Smith R.G., and Appel S.H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36 (1994) 846-858
2. Ayala G.X., and Tapia R. Expression of heat shock protein 70 induced by 4-aminopyridine through glutamate-mediated excitotoxic stress in rat hippocampus in vivo. Neuropharmacology 45 (2003) 649-660
3. Ayala G.X., and Tapia R. Late N-methyl-d-aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4-aminopyridine-induced epilepsy. Eur. J. Neurosci. 22 (2005) 3067-3076
4. 2+ exchanger in excitotoxicity. Cell 120 (2005) 275-285
5. Bar-Peled O., O'Brien R.J., Morrison J.H., and Rothstein J.D. Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. Neuroreport 10 (1999) 855-859
6. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 31 (1992) 119-130
7. Beers D.R., Ho B.K., Siklós L., Alexianu M.E., Mosier D.R., Mohamed A.H., Otsuka Y., Kozovska M.E., McAlhany R.E., Smith R.G., and Appel S.H. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem. 79 (2001) 499-509
8. Brusa R., Zimmermann F., Koh D.S., Feldmeyer D., Gass P., Seeburg P.H., and Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270 (1995) 1677-1680
9. Carriedo S.G., Yin H.Z., and Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16 (1996) 4069-4079
10. 2+ overload and ROS generation in spinal motor neurons in vitro. J. Neurosci. 20 (2000) 240-250
11. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
12. Corona J.C., and Tapia R. AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo. J. Neurochem. 89 (2004) 988-997
13. Dekkers J., Bayley P., Dick J.R., Schwaller B., Berchtold M.W., and Greensmith L. Over-expression of parvalbumin in transgenic mice rescues motoneurons from injury-induced cell death. Neuroscience 123 (2004) 459-466
14. Desagher S., Glowinski J., and Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17 (1997) 9060-9067
15. Greig A., Donevan S.D., Mujtaba T.J., Parks T.N., and Rao M.S. Characterization of the AMPA-activated receptors present on motoneurons. J. Neurochem. 74 (2000) 179-191
16. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252 (1991) 851-853
17. Hume R.I., Dingledine R., and Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 253 (1991) 1028-1031
18. Ince P., Stout N., Shaw P., Slade J., Hunziker W., Heizmann C.W., and Baimbridge K.G. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol. 19 (1993) 291-299
19. Julien J.P. Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 104 (2001) 581-591
20. Kawahara Y., Kwak S., Sun H., Ito K., Hashida H., Aizawa H., Jeong S.Y., and Kanazawa I. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J. Neurochem. 85 (2003) 680-689
21. Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., and Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 427 (2004) 801
22. Kawahara Y., Sun H., Ito K., Hideyama T., Aoki M., Sobue G., Tsuji S., and Kwak S. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci. Res. 54 (2006) 11-14
23. Kim H.J., Kim J.M., Park J.H., Sung J.J., Kim M., and Lee K.W. Pyruvate protects motor neurons expressing mutant superoxide dismutase 1 against copper toxicity. Neuroreport 16 (2005) 585-589
24. 2+-permeable AMPA receptors in cultured rat hippocampal neurons. Neurosci. Res. 29 (1997) 27-36
25. Kuner R., Groom A.J., Bresink I., Kornau H.C., Stefovska V., Muller G., Hartmann B., Tschauner K., Waibel S., Ludolph A.C., Ikonomidou C., Seeburg P.H., and Turski L. Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5826-5831
26. Kwak S., and Kawahara Y. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J. Mol. Med. 83 (2005) 110-120
27. Mallet R.T., Sun J., Knott E.M., Sharma A.B., and Olivencia-Yurvati A.H. Metabolic cardioprotection by pyruvate: recent progress. Exp. Biol. Med. 230 (2005) 435-443
28. Manfredi G., and Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5 (2005) 77-87
29. Massieu L., Morales-Villagrán A., and Tapia R. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64 (1995) 2262-2272
30. Maus M., Marin P., Israël M., Glowinski J., and Premont J. Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity. Eur. J. Neurosci. 11 (1999) 3215-3224
31. Menzies F.M., Ince P.G., and Shaw P.J. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem. Int. 40 (2002) 543-551
32. Morales-Villagrán A., and Tapia R. Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. Neurochem. Int. 28 (1996) 35-40
33. Nicholls D.G., and Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 80 (2000) 315-360
34. Noh K.M., Yokota H., Mashiko T., Castillo P.E., Zukin R.S., and Bennett M.V. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 12230-12235
35. Palecek J., Lips M.B., and Keller B.U. Calcium dynamics and buffering in motoneurones of the mouse spinal cord. J. Physiol. 520 (1999) 485-502
36. 2+-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20 (1997) 464-470
37. Peña F., and Tapia R. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Neuroscience 101 (2000) 547-561
38. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
39. Rothstein J.D. Excitotoxicity hypothesis. Neurology 47 (1996) S19-S25 [discussion S26]
40. Salazar P., Montiel T., Brailowsky S., and Tapia R. Decrease of glutamate decarboxylase activity after in vivo cortical infusion of γ-aminobutyric acid. Neurochem. Int. 24 (1994) 363-368
41. Schinder A.F., Olson E.C., Spitzer N.C., and Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16 (1996) 6125-6133
42. Siesjö B.K. Calcium-mediated processes in neuronal degeneration. Ann. N.Y. Acad. Sci. 747 (1994) 140-161
43. Siklós L., Engelhardt J.I., Alexianu M.E., Gurney M.E., Siddique T., and Appel S.H. Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. J. Neuropathol. Exp. Neurol. 57 (1998) 571-587
44. Sun H., Kawahara Y., Ito K., Kanazawa I., and Kwak S. Expression profile of AMPA receptor subunit mRNA in single adult rat brain and spinal cord neurons in situ. Neurosci. Res. 52 (2005) 228-234
45. Swerdlow R.H., Parks J.K., Cassarino D.S., Trimmer P.A., Miller S.W., Maguire D.J., Sheehan J.P., Maguire R.S., Pattee G., Juel V.C., Phillips L.H., Tuttle J.B., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 153 (1998) 135-142
46. Takuma H., Kwak S., Yoshizawa T., and Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann. Neurol. 46 (1999) 806-815
47. Tomiyama M., Rodriguez-Puertas R., Cortes R., Christnacher A., Sommer B., Pazos A., Palacios J.M., and Mengod G. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience 75 (1996) 901-915
48. Tsien R.Y. A non-disruptive technique for loading calcium buffers and indicators into cells. Nature 290 (1981) 527-528
49. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 11 (1993) 221-235
50. Van Damme P., Van Den Bosch L., Van Houtte E., Callewaert G., and Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. J. Neurophysiol. 88 (2002) 1279-1287
51. Van Damme P., Braeken D., Callewaert G., Robberecht W., and Van Den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 605-612
52. 2+-permeable AMPA receptors and selective vulnerability of motor neurons. J. Neurol. Sci. 180 (2000) 29-34
53. Van Den Bosch L., Schwaller B., Vleminckx V., Meijers B., Stork S., Ruehlicke T., Van Houtte E., Klaassen H., Celio M.R., Missiaen L., Robberecht W., and Berchtold M.W. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp. Neurol. 174 (2002) 150-161
54. Virgo L., Samarasinghe S., and de Belleroche J. Analysis of AMPA receptor subunit mRNA expression in control and ALS spinal cord. Neuroreport 7 (1996) 2507-2511
55. 2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci. 28 (2005) 494-500
56. Williams T.L., Day N.C., Ince P.G., Kamboj R.K., and Shaw P.J. Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 42 (1997) 200-207
57. 2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J. Neurosci. 22 (2002) 1273-1279